Acetylisovaleryltylosin Tartrate

Producers shown on SFDA

(Record date:26/10/2021）

Producers shown on EP

Not showing any

Producer:Qilu Pharmaceutical (Inner Mongolia) Co., Ltd., founded in 2009, is subordinate to Qilu Pharmaceutical Group Co., Ltd. It has more than 300000 square meters of production plants and supporting facilities, including R & D centers with advanced facilities, 13 production workshops and modern large warehouses.

The company has passed European EDQM registration, Australian APVMA certification and American EPA registration.

Staff size:1000-1999 people

Registered capital:RMB 50 million

Producer:Ningxia Taiyicin Biotech Co., Ltd., established in June 2010, is a wholly-owned subsidiary of Ningxia Tairui Pharmaceutical Co., Ltd. the company is based on GMP certification, ISO9001 quality management system, ISO14001 environmental management system certification of the Ministry of agriculture, FDA certification, European CEP certification and quality audit certification of key enterprises in many countries and regions. At present, many products of the company have successfully passed the GMP certification of the Ministry of agriculture and obtained the veterinary drug production license.
Staff size:1000-1999 people

Registered capital:RMB 625 million

Staff size:1000-1999 people

Registered capital:RMB 255 million 880 thousand

Producer:Inner Mongolia ZM Bio-pharmaceutical Co., Ltd.as the production base of fermentation veterinary drug raw materials (tavanillin and Flavomycin) of Zhongmu Co., Ltd., has invested 27 million yuan to expand the tavanillin project with an annual output of 42 tons, build a tavanillin tartrate extraction workshop, a 10 ton boiler room and a sewage treatment station with a daily treatment capacity of 500 tons according to the market demand and the R & D strategy of the company's new products.
Staff size:100-199 people

Registered capital:RMB 310 million

Producer:Hubei Hvsen Biotechnology Co., Ltd., established in 2009, has 13 animal GMP production lines, including non sterile API, non final sterilized large / small volume injection, final sterilized uterus / breast injection, final sterilized large / small volume injection (including traditional Chinese medicine extraction), oral solution, tablet / granule (including traditional Chinese medicine extraction), non chlorine disinfectant / insecticide and traditional Chinese medicine extraction.
Staff size:200-299 people

Registered capital:RMB 300 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978